Sudeep Pharma IPO: Key details at a glance
Sudeep Pharma's IPO opens for subscription from November 21-25, aiming to raise ₹95 crore via fresh issue and an offer-for-sale of 1.34 crore shares by promoters (OFS amount not specified in rupees in the source).
The price band is set at ₹563-593 per share, and you'll need to apply for at least 25 shares.
Share allocation splits: Up to 50% for institutional buyers, at least 35% for retail investors, and at least 15% for non-institutional investors.
What does Sudeep Pharma actually do?
Sudeep Pharma makes mineral-based ingredients used in medicines, food, and nutrition products.
With six big factories and over 200 products (think calcium, iron, magnesium salts), they're pretty established in their space.
Funds from the IPO will help upgrade machinery at their Nandesari plant and support other business needs.
Timeline & listing info
Share allotment is expected on November 26; refunds or credits should hit by November 27.
The stock is set to list on both BSE and NSE on November 28.
ICICI Securities and IIFL Capital Services are managing the IPO process.